Summary

The global Patient Blood Management (PBM) Market is experiencing significant growth, driven by increasing awareness of blood optimization strategies and patient safety initiatives. Valued at USD 15.9 billion in 2026, the market is projected to reach USD 25.2 billion by 2033, reflecting a compound annual growth rate (CAGR) of 6.8%. Patient Blood Management encompasses clinical strategies designed to minimize blood loss, reduce unnecessary transfusions, and enhance overall patient outcomes. With the rising prevalence of chronic illnesses, the growing number of surgical procedures, and an aging population, the demand for effective PBM solutions is expanding across healthcare facilities worldwide.

Market Insights

The PBM market is gaining traction as healthcare providers focus on safer and more efficient blood usage. Hospitals, blood banks, and other medical institutions are increasingly implementing PBM programs to reduce dependency on donor blood and limit transfusion-related risks. Technological innovations, such as advanced blood diagnostics, automated transfusion devices, and software solutions, are enhancing precision and efficiency in blood management. Furthermore, regulatory guidelines and initiatives encouraging standardized PBM practices are contributing to widespread adoption across developed and emerging regions.

Market Drivers

Several factors are driving the growth of the Patient Blood Management Market:

1. Growing Surgical Procedures: An increase in surgeries, including cardiovascular and orthopedic interventions, is driving demand for effective blood management solutions.

2. Blood Shortages and Safety Concerns: The limited availability of blood and the risk of transfusion-transmitted infections are accelerating adoption of PBM programs.

3. Technological Advancements: Innovative instruments, blood processing devices, and software solutions are improving the accuracy and efficiency of blood management practices.

4. Regulatory Support: Government initiatives and clinical guidelines promoting PBM protocols are encouraging healthcare institutions to implement structured programs.

5. Aging Population: The rising number of elderly patients with chronic diseases increases the need for optimized blood management during medical and surgical interventions.

Business Opportunities

The PBM market presents numerous business opportunities for manufacturers, technology providers, and service companies. Healthcare institutions are increasingly seeking integrated PBM solutions that combine diagnostic tools, transfusion devices, and software systems. The rising adoption of point-of-care diagnostics and automated transfusion management platforms provides opportunities for innovation and differentiation. Companies offering training, consulting, and software-based solutions for real-time blood inventory management are well-positioned to leverage the market’s growth.

Regional Analysis

The Patient Blood Management Market exhibits robust growth across all major regions:

• North America: The region remains a leader due to advanced healthcare infrastructure, widespread adoption of PBM programs, and supportive regulatory frameworks.

• Europe: Rising surgical procedures and strict transfusion safety regulations are driving growth in European countries.

• Asia Pacific: Rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and rising awareness of PBM benefits make this region a key growth market.

• Latin America: Investments in healthcare infrastructure and the adoption of standardized blood management practices are fueling market growth.

• Middle East & Africa: Growing chronic disease prevalence and government-led initiatives to improve blood safety are supporting PBM adoption.

Key Players

The Patient Blood Management Market is highly competitive, with several global and regional players leading innovation and adoption:

• Haemonetics Corporation

• Fresenius Kabi

• Terumo Corporation

• Grifols, S.A.

• World Courier / AmerisourceBergen

• Cerner Corporation (Oracle Health)

• Siemens Healthineers

• Abbott Laboratories

• Baxter International Inc.

• GE Healthcare

• Medtronic plc

• Stryker Corporation

• Mobius Imaging, LLC

• Pentec Health, Inc.

• Haemokinesis, Inc.

These companies focus on research and development, strategic collaborations, and regional expansion to strengthen their market presence. Innovations in blood storage, processing, and software solutions are key differentiators in this competitive landscape.

Market Segmentation

By Product:

• Instruments

• Blood Processing Devices

• Blood Transfusion Devices

• Blood Culture Screening Devices

• Diagnostic & Testing Instruments

• Blood Storage Devices

• Accessories

• Syringes & Needles

• Vials & Tubes

• Blood Bags

• Other Accessories

• Reagents and Kits

• Culture Media

• Blood Typing Reagents

• Slide Staining

• Assay Kits

• Others

• Software

• Blood Bank and Transfusion Software

• Others

By Component:

• Whole Blood

• Blood Components

By End User:

• Hospitals

• Blood Banks

By Region:

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Patient Blood Management Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Fiver Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Patient Blood Management Market Outlook, 2020 - 2033
3.1. Global Patient Blood Management Market Outlook, by Product, Value (US$ Bn), 2020-2033
3.1.1. Instruments
3.1.1.1. Blood Processing Devices
3.1.1.2. Blood Transfusion Devices
3.1.1.3. Blood Culture Screening Devices
3.1.1.4. Diagnostic & Testing Instruments
3.1.1.5. Blood Storage Devices
3.1.2. Accessories
3.1.2.1. Syringes & Needles
3.1.2.2. Vials & Tubes
3.1.2.3. Blood Bags
3.1.2.4. Other Accessories
3.1.3. Reagents and Kits
3.1.3.1. Culture Media
3.1.3.2. Blood Typing Reagents
3.1.3.3. Slide Staining
3.1.3.4. Assay Kits
3.1.3.5. Others
3.1.4. Software
3.1.4.1. Blood Bank and Transfusion Software
3.1.4.2. Others
3.2. Global Patient Blood Management Market Outlook, by Component, Value (US$ Bn), 2020-2033
3.2.1. Whole Blood
3.2.2. Blood Components
3.3. Global Patient Blood Management Market Outlook, by End User, Value (US$ Bn), 2020-2033
3.3.1. Hospitals
3.3.2. Blood Banks
3.4. Global Patient Blood Management Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
4. North America Patient Blood Management Market Outlook, 2020 - 2033
4.1. North America Patient Blood Management Market Outlook, by Product, Value (US$ Bn), 2020-2033
4.1.1. Instruments
4.1.1.1. Blood Processing Devices
4.1.1.2. Blood Transfusion Devices
4.1.1.3. Blood Culture Screening Devices
4.1.1.4. Diagnostic & Testing Instruments
4.1.1.5. Blood Storage Devices
4.1.2. Accessories
4.1.2.1. Syringes & Needles
4.1.2.2. Vials & Tubes
4.1.2.3. Blood Bags
4.1.2.4. Other Accessories
4.1.3. Reagents and Kits
4.1.3.1. Culture Media
4.1.3.2. Blood Typing Reagents
4.1.3.3. Slide Staining
4.1.3.4. Assay Kits
4.1.3.5. Others
4.1.4. Software
4.1.4.1. Blood Bank and Transfusion Software
4.1.4.2. Others
4.2. North America Patient Blood Management Market Outlook, by Component, Value (US$ Bn), 2020-2033
4.2.1. Whole Blood
4.2.2. Blood Components
4.3. North America Patient Blood Management Market Outlook, by End User, Value (US$ Bn), 2020-2033
4.3.1. Hospitals
4.3.2. Blood Banks
4.4. North America Patient Blood Management Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.4.1. U.S. Patient Blood Management Market Outlook, by Product, 2020-2033
4.4.2. U.S. Patient Blood Management Market Outlook, by Component, 2020-2033
4.4.3. U.S. Patient Blood Management Market Outlook, by End User, 2020-2033
4.4.4. Canada Patient Blood Management Market Outlook, by Product, 2020-2033
4.4.5. Canada Patient Blood Management Market Outlook, by Component, 2020-2033
4.4.6. Canada Patient Blood Management Market Outlook, by End User, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Patient Blood Management Market Outlook, 2020 - 2033
5.1. Europe Patient Blood Management Market Outlook, by Product, Value (US$ Bn), 2020-2033
5.1.1. Instruments
5.1.1.1. Blood Processing Devices
5.1.1.2. Blood Transfusion Devices
5.1.1.3. Blood Culture Screening Devices
5.1.1.4. Diagnostic & Testing Instruments
5.1.1.5. Blood Storage Devices
5.1.2. Accessories
5.1.2.1. Syringes & Needles
5.1.2.2. Vials & Tubes
5.1.2.3. Blood Bags
5.1.2.4. Other Accessories
5.1.3. Reagents and Kits
5.1.3.1. Culture Media
5.1.3.2. Blood Typing Reagents
5.1.3.3. Slide Staining
5.1.3.4. Assay Kits
5.1.3.5. Others
5.1.4. Software
5.1.4.1. Blood Bank and Transfusion Software
5.1.4.2. Others
5.2. Europe Patient Blood Management Market Outlook, by Component, Value (US$ Bn), 2020-2033
5.2.1. Whole Blood
5.2.2. Blood Components
5.3. Europe Patient Blood Management Market Outlook, by End User, Value (US$ Bn), 2020-2033
5.3.1. Hospitals
5.3.2. Blood Banks
5.4. Europe Patient Blood Management Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.4.1. Germany Patient Blood Management Market Outlook, by Product, 2020-2033
5.4.2. Germany Patient Blood Management Market Outlook, by Component, 2020-2033
5.4.3. Germany Patient Blood Management Market Outlook, by End User, 2020-2033
5.4.4. Italy Patient Blood Management Market Outlook, by Product, 2020-2033
5.4.5. Italy Patient Blood Management Market Outlook, by Component, 2020-2033
5.4.6. Italy Patient Blood Management Market Outlook, by End User, 2020-2033
5.4.7. France Patient Blood Management Market Outlook, by Product, 2020-2033
5.4.8. France Patient Blood Management Market Outlook, by Component, 2020-2033
5.4.9. France Patient Blood Management Market Outlook, by End User, 2020-2033
5.4.10. U.K. Patient Blood Management Market Outlook, by Product, 2020-2033
5.4.11. U.K. Patient Blood Management Market Outlook, by Component, 2020-2033
5.4.12. U.K. Patient Blood Management Market Outlook, by End User, 2020-2033
5.4.13. Spain Patient Blood Management Market Outlook, by Product, 2020-2033
5.4.14. Spain Patient Blood Management Market Outlook, by Component, 2020-2033
5.4.15. Spain Patient Blood Management Market Outlook, by End User, 2020-2033
5.4.16. Russia Patient Blood Management Market Outlook, by Product, 2020-2033
5.4.17. Russia Patient Blood Management Market Outlook, by Component, 2020-2033
5.4.18. Russia Patient Blood Management Market Outlook, by End User, 2020-2033
5.4.19. Rest of Europe Patient Blood Management Market Outlook, by Product, 2020-2033
5.4.20. Rest of Europe Patient Blood Management Market Outlook, by Component, 2020-2033
5.4.21. Rest of Europe Patient Blood Management Market Outlook, by End User, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Patient Blood Management Market Outlook, 2020 - 2033
6.1. Asia Pacific Patient Blood Management Market Outlook, by Product, Value (US$ Bn), 2020-2033
6.1.1. Instruments
6.1.1.1. Blood Processing Devices
6.1.1.2. Blood Transfusion Devices
6.1.1.3. Blood Culture Screening Devices
6.1.1.4. Diagnostic & Testing Instruments
6.1.1.5. Blood Storage Devices
6.1.2. Accessories
6.1.2.1. Syringes & Needles
6.1.2.2. Vials & Tubes
6.1.2.3. Blood Bags
6.1.2.4. Other Accessories
6.1.3. Reagents and Kits
6.1.3.1. Culture Media
6.1.3.2. Blood Typing Reagents
6.1.3.3. Slide Staining
6.1.3.4. Assay Kits
6.1.3.5. Others
6.1.4. Software
6.1.4.1. Blood Bank and Transfusion Software
6.1.4.2. Others
6.2. Asia Pacific Patient Blood Management Market Outlook, by Component, Value (US$ Bn), 2020-2033
6.2.1. Whole Blood
6.2.2. Blood Components
6.3. Asia Pacific Patient Blood Management Market Outlook, by End User, Value (US$ Bn), 2020-2033
6.3.1. Hospitals
6.3.2. Blood Banks
6.4. Asia Pacific Patient Blood Management Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.4.1. China Patient Blood Management Market Outlook, by Product, 2020-2033
6.4.2. China Patient Blood Management Market Outlook, by Component, 2020-2033
6.4.3. China Patient Blood Management Market Outlook, by End User, 2020-2033
6.4.4. Japan Patient Blood Management Market Outlook, by Product, 2020-2033
6.4.5. Japan Patient Blood Management Market Outlook, by Component, 2020-2033
6.4.6. Japan Patient Blood Management Market Outlook, by End User, 2020-2033
6.4.7. South Korea Patient Blood Management Market Outlook, by Product, 2020-2033
6.4.8. South Korea Patient Blood Management Market Outlook, by Component, 2020-2033
6.4.9. South Korea Patient Blood Management Market Outlook, by End User, 2020-2033
6.4.10. India Patient Blood Management Market Outlook, by Product, 2020-2033
6.4.11. India Patient Blood Management Market Outlook, by Component, 2020-2033
6.4.12. India Patient Blood Management Market Outlook, by End User, 2020-2033
6.4.13. Southeast Asia Patient Blood Management Market Outlook, by Product, 2020-2033
6.4.14. Southeast Asia Patient Blood Management Market Outlook, by Component, 2020-2033
6.4.15. Southeast Asia Patient Blood Management Market Outlook, by End User, 2020-2033
6.4.16. Rest of SAO Patient Blood Management Market Outlook, by Product, 2020-2033
6.4.17. Rest of SAO Patient Blood Management Market Outlook, by Component, 2020-2033
6.4.18. Rest of SAO Patient Blood Management Market Outlook, by End User, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Patient Blood Management Market Outlook, 2020 - 2033
7.1. Latin America Patient Blood Management Market Outlook, by Product, Value (US$ Bn), 2020-2033
7.1.1. Instruments
7.1.1.1. Blood Processing Devices
7.1.1.2. Blood Transfusion Devices
7.1.1.3. Blood Culture Screening Devices
7.1.1.4. Diagnostic & Testing Instruments
7.1.1.5. Blood Storage Devices
7.1.2. Accessories
7.1.2.1. Syringes & Needles
7.1.2.2. Vials & Tubes
7.1.2.3. Blood Bags
7.1.2.4. Other Accessories
7.1.3. Reagents and Kits
7.1.3.1. Culture Media
7.1.3.2. Blood Typing Reagents
7.1.3.3. Slide Staining
7.1.3.4. Assay Kits
7.1.3.5. Others
7.1.4. Software
7.1.4.1. Blood Bank and Transfusion Software
7.1.4.2. Others
7.2. Latin America Patient Blood Management Market Outlook, by Component, Value (US$ Bn), 2020-2033
7.2.1. Whole Blood
7.2.2. Blood Components
7.3. Latin America Patient Blood Management Market Outlook, by End User, Value (US$ Bn), 2020-2033
7.3.1. Hospitals
7.3.2. Blood Banks
7.4. Latin America Patient Blood Management Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.4.1. Brazil Patient Blood Management Market Outlook, by Product, 2020-2033
7.4.2. Brazil Patient Blood Management Market Outlook, by Component, 2020-2033
7.4.3. Brazil Patient Blood Management Market Outlook, by End User, 2020-2033
7.4.4. Mexico Patient Blood Management Market Outlook, by Product, 2020-2033
7.4.5. Mexico Patient Blood Management Market Outlook, by Component, 2020-2033
7.4.6. Mexico Patient Blood Management Market Outlook, by End User, 2020-2033
7.4.7. Argentina Patient Blood Management Market Outlook, by Product, 2020-2033
7.4.8. Argentina Patient Blood Management Market Outlook, by Component, 2020-2033
7.4.9. Argentina Patient Blood Management Market Outlook, by End User, 2020-2033
7.4.10. Rest of LATAM Patient Blood Management Market Outlook, by Product, 2020-2033
7.4.11. Rest of LATAM Patient Blood Management Market Outlook, by Component, 2020-2033
7.4.12. Rest of LATAM Patient Blood Management Market Outlook, by End User, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Patient Blood Management Market Outlook, 2020 - 2033
8.1. Middle East & Africa Patient Blood Management Market Outlook, by Product, Value (US$ Bn), 2020-2033
8.1.1. Instruments
8.1.1.1. Blood Processing Devices
8.1.1.2. Blood Transfusion Devices
8.1.1.3. Blood Culture Screening Devices
8.1.1.4. Diagnostic & Testing Instruments
8.1.1.5. Blood Storage Devices
8.1.2. Accessories
8.1.2.1. Syringes & Needles
8.1.2.2. Vials & Tubes
8.1.2.3. Blood Bags
8.1.2.4. Other Accessories
8.1.3. Reagents and Kits
8.1.3.1. Culture Media
8.1.3.2. Blood Typing Reagents
8.1.3.3. Slide Staining
8.1.3.4. Assay Kits
8.1.3.5. Others
8.1.4. Software
8.1.4.1. Blood Bank and Transfusion Software
8.1.4.2. Others
8.2. Middle East & Africa Patient Blood Management Market Outlook, by Component, Value (US$ Bn), 2020-2033
8.2.1. Whole Blood
8.2.2. Blood Components
8.3. Middle East & Africa Patient Blood Management Market Outlook, by End User, Value (US$ Bn), 2020-2033
8.3.1. Hospitals
8.3.2. Blood Banks
8.4. Middle East & Africa Patient Blood Management Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.4.1. GCC Patient Blood Management Market Outlook, by Product, 2020-2033
8.4.2. GCC Patient Blood Management Market Outlook, by Component, 2020-2033
8.4.3. GCC Patient Blood Management Market Outlook, by End User, 2020-2033
8.4.4. South Africa Patient Blood Management Market Outlook, by Product, 2020-2033
8.4.5. South Africa Patient Blood Management Market Outlook, by Component, 2020-2033
8.4.6. South Africa Patient Blood Management Market Outlook, by End User, 2020-2033
8.4.7. Egypt Patient Blood Management Market Outlook, by Product, 2020-2033
8.4.8. Egypt Patient Blood Management Market Outlook, by Component, 2020-2033
8.4.9. Egypt Patient Blood Management Market Outlook, by End User, 2020-2033
8.4.10. Nigeria Patient Blood Management Market Outlook, by Product, 2020-2033
8.4.11. Nigeria Patient Blood Management Market Outlook, by Component, 2020-2033
8.4.12. Nigeria Patient Blood Management Market Outlook, by End User, 2020-2033
8.4.13. Rest of Middle East Patient Blood Management Market Outlook, by Product, 2020-2033
8.4.14. Rest of Middle East Patient Blood Management Market Outlook, by Component, 2020-2033
8.4.15. Rest of Middle East Patient Blood Management Market Outlook, by End User, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Haemonetics Corporation
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Fresenius Kabi
9.4.3. Terumo Corporation
9.4.4. Grifols, S.A.
9.4.5. World Courier / AmerisourceBergen
9.4.6. Cerner Corporation (Oracle Health)
9.4.7. Siemens Healthineers
9.4.8. Abbott Laboratories
9.4.9. Baxter International Inc.
9.4.10. GE Healthcare
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations